Roger C. Lucas, Director at ChemoCentryx, Inc. (CCXI), sold 2,250 shares at $10.07 ($23K) on 2017-08-01, disclosed to the SEC on 2017-08-03.
Scheduled sale ($23k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TECH | SELL | 2017-08-14 | $11K | — | Filing → |
| TECH | SELL | 2017-07-12 | $12K | — | Filing → |
| TECH | SELL | 2017-06-13 | $11K | — | Filing → |